Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.
Recent advancements in endometriosis research are transforming treatment, focusing on non-surgical interventions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback